Literature DB >> 27334229

Emerging roles of the processing of nucleic acids and Toll-like receptors in innate immune responses to nucleic acids.

Kensuke Miyake1, Takuma Shibata2, Umeharu Ohto3, Toshiyuki Shimizu3.   

Abstract

Nucleic acid (NA) is continuously degraded in lysosomes, cytoplasm, and nucleus. NA degradation has a key role in preventing hazardous activation of NA sensors. DNA degradation by lysosomal and cytoplasmic DNases prevents homeostatic activation of cytoplasmic DNA sensing pathways. Crude NA, however, is not sufficient for stimulating NA sensors. mRNAs and rRNAs need to be processed by inositol-requiring enzyme 1 (IRE-1) or RNase L before stimulating cytoplasmic RNA sensors. Activation of cytoplasmic RNA sensors by processed RNAs is tightly controlled by their degradation through the machineries, such as RNA editing, by adenosine (A) deaminases that act on RNA 1 (ADAR1) and the RNA exosome. Impaired degradation of processed RNAs in humans causes activation of cytoplasmic RNA sensors, leading to Aicardi-Goutières syndrome or trichohepatoenteric syndrome. Lysosomal TLRs are also dependent on NA processing in lysosomes. Digestion of dsDNA by DNase II is required for TLR9 response to ssDNA. TLR7 and TLR8 respond to ribonucleosides and oligoribonucleotides, instead of ssRNA itself, indicating requirement for RNA processing. NA-sensing TLRs themselves need to be processed by lysosomal proteases. Without processing, TLR8 and TLR9 fail to form dimers. In addition to NA degradation, the processing of NAs and TLRs by a variety of enzymes is an emerging concept on the control of innate immune responses to NAs. © Society for Leukocyte Biology.

Entities:  

Keywords:  DNase; RNase; guanosine; uridine

Mesh:

Substances:

Year:  2016        PMID: 27334229     DOI: 10.1189/jlb.4MR0316-108R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

Review 1.  Intracellular Nucleic Acid Detection in Autoimmunity.

Authors:  John T Crowl; Elizabeth E Gray; Kathleen Pestal; Hannah E Volkman; Daniel B Stetson
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

Review 2.  Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity.

Authors:  GuanQun Liu; Michaela U Gack
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

Review 3.  Pharmacologic Protection of Mitochondrial DNA Integrity May Afford a New Strategy for Suppressing Lung Ischemia-Reperfusion Injury.

Authors:  Yong B Tan; Sujata Mulekar; Olena Gorodnya; Michael J Weyant; Martin R Zamora; Jon D Simmons; Tiago Machuka; Mark N Gillespie
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 4.  Nucleic acid-sensing TLRs: trafficking and regulation.

Authors:  Olivia Majer; Bo Liu; Gregory M Barton
Journal:  Curr Opin Immunol       Date:  2016-11-28       Impact factor: 7.486

5.  Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B.

Authors:  Steffen Wildum; Kyle E Korolowicz; Manasa Suresh; Guido Steiner; Lue Dai; Bin Li; Changsuek Yon; Maria Cristina De Vera Mudry; Franziska Regenass-Lechner; Xu Huang; Xupeng Hong; Marta G Murreddu; Bhaskar V Kallakury; John A T Young; Stephan Menne
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

Review 6.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

7.  Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus.

Authors:  Kyle E Korolowizc; Bin Li; Xu Huang; Changsuek Yon; Evelyn Rodrigo; Manny Corpuz; David M Plouffe; Bhaskar V Kallakury; Manasa Suresh; Tom Y-H Wu; Andrew T Miller; Stephan Menne
Journal:  Hepatol Commun       Date:  2019-07-08

8.  Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.

Authors:  Cedric Cappel; Adriana Carolina Gonzalez; Markus Damme
Journal:  J Biol Chem       Date:  2020-12-10       Impact factor: 5.157

9.  Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Kyle E Korolowicz; Manasa Suresh; Bin Li; Xu Huang; Changsuek Yon; Xuebing Leng; Bhaskar V Kallakury; Robin D Tucker; Stephan Menne
Journal:  Viruses       Date:  2021-04-09       Impact factor: 5.048

Review 10.  Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants.

Authors:  Sachin Bhagchandani; Jeremiah A Johnson; Darrell J Irvine
Journal:  Adv Drug Deliv Rev       Date:  2021-05-29       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.